Immage Biotherapeutics Corp. (IMMG) Research

Presently, Immage Biotherapeutics Corp. lacks substantial business operations. Historically, its endeavors centered on the creation of cutting-edge immunotherapy biologics designed to combat diverse cancer types across the United States. Established in 2012, the entity was initially known as Epicure Charcoal, Inc., rebranding to Immage Biotherapeutics Corp. in June 2015. Its corporate headquarters are situated in Bethesda, Maryland, and it operates as a subsidiary of Coventry International Limited.

Market snapshot

Symbol
IMMG
Price
$0.00
Day change
0.00%
Market cap
$15.2K
P/E ratio
-0.07x
52-week range
0.000001-0.0001
Sector
Financial Services
Industry
Financial - Conglomerates

Peer companies

  • Axis Technologies Group, Inc. (AXTG)
  • First Bitcoin Capital Corp. (BITCF)
  • BLOK Technologies Inc. (BLPFF)
  • China Finance, Inc. (CHFI)
  • CTR Investments & Consulting, Inc. (CIVX)
  • AgriEuro Corp. (EURI)
  • Rainbow International Corp. (RNBI)
  • Ever Harvest International Group Inc. (TLGN)

Open Immage Biotherapeutics Corp. (IMMG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.